UMediC Appoints Affin Hwang Investment As Underwriter For Its IPO

Jun 3, 2022 | News | 0 comments

UMediC Group Berhad has appointed Affin Hwang Investment Bank Berhad as its Principal Adviser, Sponsor, Sole Placement Agent, and Sole Underwriter for the group’s initial public offering on the ACE Market of Bursa Malaysia Securities.

The group’s IPO will involve the public issue of 97,224,300 new shares and has received approval from Bursa Securities for the admission to the Official List of Bursa Securities and the listing of and quotation for the entire enlarged issued share capital of the Company comprising 373,910,000 shares.

UMC distributes various branded medical devices and consumables as well as provisions after-sales service for all its products. Apart from that, it is involved in developing, manufacturing, and marketing of its medical consumables. With around 20 years of market presence, UMC Group has established itself as a reputable distributor of medical devices and consumables.

Mr. Lim Taw Seong said, “We aim to further strengthen our position as a distributor of medical devices in the local market and a manufacturer of medical consumables to be distributed in both the local and international markets”